Inside Sera Prognostics: Why the Latest Sell‑to‑Cover Move Matters to Investors
Insight into Sera Prognostics insider sell‑to‑cover: how a routine tax‑cover trade by its chief medical officer affects investors and market sentiment.
3 minutes to read